Dopamine D3 Receptor Plasticity in Parkinson’s Disease and L-DOPA-Induced Dyskinesia

Parkinson’s Disease (PD) is characterized by primary and secondary plasticity that occurs in response to progressive degeneration and long-term L-DOPA treatment. Some of this plasticity contributes to the detrimental side effects associated with chronic L-DOPA treatment, namely L-DOPA-induced dyskin...

Descripción completa

Detalles Bibliográficos
Autores principales: Lanza, Kathryn, Bishop, Christopher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003204/
https://www.ncbi.nlm.nih.gov/pubmed/33808538
http://dx.doi.org/10.3390/biomedicines9030314

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003204/
https://www.ncbi.nlm.nih.gov/pubmed/33808538
http://dx.doi.org/10.3390/biomedicines9030314

Ejemplares similares